Registry of Lobbyists
Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Health
|
Discuss Canada's response to the proposed bulk importation of medications from Canada to the United States.
|
Policies or Program, Regulation
|
|
Health
|
Ensure patient organizations are consulted and provide feedback on policies, processes, patient representation and other initiatives from Canada's Drug Agency.
|
Policies or Program
|
|
Health
|
Ensure timely access to a comprehensive range of medicines, vaccines and related treatments and protect access to clinical trials, while helping to rebuild domestic capacities to develop and make drugs and vaccines.
|
Policies or Program, Regulation
|
|
Health
|
Learn more about and provide feedback on plans around COVID-19 vaccines, including protein based ones.
|
Policies or Program
|
|
Health
|
Provide input on a national strategy for drugs for rare diseases.
|
Policies or Program
|
|
Health
|
Provide input on pharmacare.
|
Policies or Program
|
|
Health
|
Provide input on the government's response to tariffs and other trade measures as they relate to pharmaceuticals and related treatments, including their ingredients, as well as other health products and devices. Also recommend providing financial relief to patients impacted by price increases.
|
Grant, Contribution or Other Financial Benefit, Regulation, Policies or Program
|
|
Health
|
Recommend that the government and regulators adopt proactive approaches to communicating drug supply and shortages issues and measures to address them.
|
Regulation, Policies or Program
|
|
Health
|
Recommend the creation of a Chief Patient Officer.
|
Policies or Program
|
|
Health
|
Recommend the creation of a Patient Ombudsman.
|
Policies or Program
|
|
Health
|
Share patient groups perspectives on drug pricing and access to medications/vaccines/clinical trials, specifically regulations and guidelines related to the Patented Medicine Prices Review Board, along with feedback on their policies and practices, and processes related to PMPRB.
|
Policies or Program, Regulation
|
|
Health
|
Support input into the consultation on Canada Gazette, Part I, Volume 159, Number 51: Order Providing for Reliance on Decisions of, or Documents Produced by, Foreign Regulatory Authorities in Respect of Certain Drugs.
|
Regulation
|
|
Health
|
Support input into the consultation on draft guidance on decentralized clinical trials.
|
Regulation, Policies or Program
|
|
Health
|
Support input regarding Canada’s pharmaceutical sovereignty.
|
Policies or Program, Regulation
|
Address:
278 Markland Drive
Toronto, ON M9C 1R7
Canada
Telephone number:
647-677-0736
Fax number:
888-484-3938
Web address:
https://bestmedicinescoalition.org
Kim Steele, Chair of the Board of Directors
Best Medicines Coalition / Coalition pour de meilleurs médicaments is not a subsidiary of any other parent companies.
The activities of Best Medicines Coalition / Coalition pour de meilleurs médicaments are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Best Medicines Coalition / Coalition pour de meilleurs médicaments does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Mirianna Georges | No public offices held
Firm: Santis Health